Onderneming Arch Therapeutics, Inc. Other OTC
Aandelen
ARTH
US03939W1099
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biotechnology
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +383,80% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +383,80% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 10-05-21 |
Shawn Carlson
SAM | Sales & Marketing | - | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Fish Guy
BRD | Director/Board Member | 64 | 31-12-21 |
Laurence Hicks
BRD | Director/Board Member | - | 27-09-21 |
Punit Dhillon
BRD | Director/Board Member | 44 | 01-07-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 444 363 | 3 252 501 ( 73,18 %) | 0 | 73,18 % |
Bedrijfsgegevens
![Adres Arch Therapeutics, Inc.(ARTH)](https://cdn.zonebourse.com/static/address/28376861.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,20% | 131 mld. | |
-7,32% | 11,05 mld. | |
-11,58% | 7,71 mld. | |
+41,65% | 5,67 mld. | |
-18,05% | 4,95 mld. | |
+7,99% | 3,43 mld. | |
-19,96% | 2,46 mld. | |
-15,76% | 1,97 mld. | |
-16,68% | 1,85 mld. |